← Back
Data updated: Jul 17, 2026
MAYER LABS INC
Specialty Pharmaceuticals
MAYER LABS INC is a specialty pharmaceutical company with 1 FDA-approved products.
1983
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
MAYER LABS INC's Key Drugs
MAYER LABS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
MAYER LABS INC's Recent FDA Approvals
New NDA/BLA approvals for MAYER LABS INC over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
MAYER LABS INC's Therapeutic Areas
Disease areas where MAYER LABS INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
MAYER LABS INC Pipeline Snapshot
Active clinical trials for MAYER LABS INC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1983-04-01
- Latest
- 2014-12-15
- Applications
- 1